<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Anaemias: megaloblastic; Vitamin B12; Anaemias: pernicious; Gastrectomy: vitamin B12; Hydroxocobalamin: anaemias; Folic acid; Folate: deficiency; Calcium folinate; Calcium leucovorin see Calcium folinate; Neural tube defects, prevention; Folic acid: pregnancy; Pregnancy: folate supplements" /><meta name="IX" content="Anaemias: megaloblastic; Vitamin B12; Anaemias: pernicious; Gastrectomy: vitamin B12; Hydroxocobalamin: anaemias; Folic acid; Folate: deficiency; Calcium folinate; Neural tube defects, prevention; Folic acid: pregnancy; Pregnancy: folate supplements" /><meta name="IXN" content="Calcium leucovorin see Calcium folinate" /><title>9.1.2 Drugs used in megaloblastic anaemias: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="4901.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="4901.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=4901.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2076.htm">9 Nutrition and blood</a> &gt; <a href="4843.htm">9.1 Anaemias and some other blood disorders</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129557.htm" title="Previous: IRON SUCROSE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4902.htm" title="Next: HYDROXOCOBALAMIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_4901">9.1.2 Drugs used in megaloblastic anaemias</h1><?highlighter on?><div id="pC" class="jN"><div><div id="_4901.1"><p>Most megaloblastic anaemias result
from a lack of either vitamin B<sub>12</sub> or folate, and it is essential
to establish in every case which deficiency is present and the underlying
cause. In emergencies, when delay might be dangerous, it is sometimes
necessary to administer both substances after the bone marrow test
while plasma assay results are awaited. Normally, however, appropriate
treatment should not be instituted until the results of tests are
available.</p></div><p>One cause of megaloblastic anaemia in the UK
is <i>pernicious anaemia</i> in which lack of gastric intrinsic factor
resulting from an autoimmune gastritis causes malabsorption of vitamin
B<sub>12</sub>.</p><p>Vitamin B<sub>12</sub> is also needed in the treatment of megaloblastosis
caused by <i>prolonged <span>nitrous oxide</span> anaesthesia</i>, which inactivates the vitamin, and in the rare syndrome of <i>congenital transcobalamin II deficiency</i>.</p><p>Vitamin B<sub>12</sub> should be given prophylactically after <i>total gastrectomy</i> or <i>total ileal resection</i> (or
after <i>partial gastrectomy</i> if a vitamin B<sub>12</sub> absorption test shows vitamin B<sub>12</sub> malabsorption).</p><p>Apart from dietary deficiency, all other causes of vitamin B<sub>12</sub> deficiency are attributable to malabsorption. There is little
place for the use of low-dose vitamin B<sub>12</sub> orally and none
for vitamin B<sub>12</sub> intrinsic factor complexes given by mouth.
Vitamin B<sub>12</sub> in larger oral doses of 1–2 mg daily [unlicensed]
may be effective.</p><p><b><span>Hydroxocobalamin</span></b> has completely
replaced <span>cyanocobalamin</span> as the form of vitamin
B<sub>12</sub> of choice for therapy; it is retained in the body longer
than <span>cyanocobalamin</span> and thus for maintenance therapy
can be given at intervals of up to 3 months. Treatment is generally
initiated with frequent administration of intramuscular injections
to replenish the depleted body stores. Thereafter, maintenance treatment,
which is usually for life, can be instituted. There is no evidence
that doses larger than those recommended provide any additional benefit
in vitamin B<sub>12</sub> neuropathy.</p><p><b><span>Folic acid</span></b> has few indications for long-term therapy
since most causes of folate deficiency are self-limiting or will yield to a short course
of treatment. It should not be used in undiagnosed megaloblastic
anaemia unless vitamin B<sub>12</sub> is administered concurrently otherwise neuropathy may be precipitated (see above).</p><p>In <i>folate-deficient megaloblastic anaemia</i> (e.g.
because of poor nutrition, pregnancy, or antiepileptic drugs), daily <span>folic acid</span> supplementation for 4 months brings about haematological
remission and replenishes body stores.</p><p>For prophylaxis in <i>chronic haemolytic states</i>, <i>malabsorption</i>, or <i>in renal dialysis</i>, <span>folic acid</span> is given daily or sometimes weekly,
depending on the diet and the rate of haemolysis.</p><p>For <i>prophylaxis in pregnancy,</i> see <a title="target-block: neural tube defects" href="4901.htm#_120004">Prevention of Neural Tube Defects</a> below.</p><p>Folic acid is also used for the prevention of methotrexate-induced
side-effects in severe Crohn’s disease (see <a title="BNF:sub-section: Drugs affecting the immune response" href="201291.htm#_201291">section 1.5.3</a>),
rheumatic disease (see <a title="BNF:monograph-family: Drugs affecting the immune response" href="5304.htm#_5304">section 10.1.3</a>),
and severe psoriasis (see <a title="BNF:target-block: methotrexatesideeffects" href="106473.htm#_202252">section 13.5.3</a>).</p><p><b>Folinic acid</b> is also effective in the treatment
of folate-deficient megaloblastic anaemia but it is generally used
in association with cytotoxic drugs (see <a title=" Cytotoxic drugs" href="4676.htm#_4676">section 8.1</a>); it is given as <span>calcium folinate</span>.</p><div id="_120004"><div class="cAZ"><h2>Prevention of neural tube defects</h2> <p class="cAX">Folic acid supplements
taken before and during pregnancy can reduce the occurrence of neural
tube defects. The risk of a neural tube defect occurring in a child
should be assessed and folic acid given as follows:</p><ul class="cBD"><li><p class="cQ">Women at a low risk of conceiving a child with a neural
tube defect should be advised to take folic acid as a medicinal or
food supplement at a dose of 400 micrograms daily before conception
and until week 12 of pregnancy. Women who have not been taking folic
acid and who suspect they are pregnant should start at once and continue
until week 12 of pregnancy.</p></li><li><p class="cQ">Couples are at a high risk of conceiving a child with
a neural tube defect if either partner has a neural tube defect (or
either partner has a family history of neural tube defects), if they
have had a previous pregnancy affected by a neural tube defect, or
if the woman has coeliac disease (or other malabsorption state), diabetes
mellitus, sickle-cell anaemia, or is taking antiepileptic medicines
(see also <a title="target-block: Pregnancy and breast-feeding in epilepsy" href="3575.htm#_120546">section 4.8.1</a>).</p></li><li><p class="cQ">Women in the high-risk group who wish to become pregnant
(or who are at risk of becoming pregnant) should be advised to take
folic acid 5 mg daily and continue until week 12 of pregnancy (women
with sickle-cell disease should continue taking their normal dose
of folic acid 5 mg daily (or to increase the dose to 5 mg daily) and
continue this throughout pregnancy).</p></li></ul></div></div><div class="cN"><p>There is <b>no</b> justification for prescribing
multiple-ingredient vitamin preparations containing vitamin B<sub>12</sub> or <span>folic acid</span>.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_4902"><a href="4902.htm" title="HYDROXOCOBALAMIN">HYDROXOCOBALAMIN</a></li><li id="_4904"><a href="4904.htm" title="CYANOCOBALAMIN">CYANOCOBALAMIN</a></li><li id="_4906"><a href="4906.htm" title="FOLIC ACID">FOLIC ACID</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129557.htm">Previous: IRON SUCROSE</a> | <a class="top" href="4901.htm#">Top</a> | <a accesskey="]" href="4902.htm">Next: HYDROXOCOBALAMIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>